top of page
Home
About
Portfolio
Science
Media
News
Press
Contact Us
More
Use tab to navigate through the menu items.
Press
Integrated Biosciences Raises $17 Million to Accelerate Development of Drugs Targeting Age-Related Diseases
October 3, 2024
LIfT BioSciences raises £10m in first close of Series A to advance first-in-class allogeneic innate cell therapy
September 24, 2024
LifeSpan Vision Featured In FINSMES "
Remedium Bio Receives Investment from LifeSpan Vision Ventures"
September 11, 2024
LifeSpan Vision Featured In PR Newswire "
LifeSpan Vision Ventures Invests in Remedium Bio"
September 10, 2024
LifeSpan Vision Featured In Yahoo Finance "
LifeSpan Vision Ventures Invests in Remedium Bio"
September 10, 2024
LifeSpan Vision Featured In PR Newswire "
Matter Bio Successfully Closes $7M Seed Funding Round"
May 29, 2024
LifeSpan Vision Featured In Longevity "
Matter Bio lands seed funding for longevity therapeutics that preserve genomic integrity"
May 29, 2024
SENISCA secures additional £3.7 million financing to support rapid development of senotherapeutic platform
March , 2024
LifeSpan Vision Featured In FINSMES "NaNotics Receives Investment From LifeSpan Vision Ventures"
October 31, 2023
LifeSpan Vision Featured In WestFair "Norwalk’s LifeSpan Vision Ventures Invests in Rejuvenation Technologies"
October 16, 2023
LifeSpan Vision Featured In BioSpace "LifeSpan Vision Ventures Invests in Deciduous Therapeutics"
October 3, 2023
LifeSpan Vision Featured In FOX59 "LifeSpan Vision Ventures Launched To Focus On Longevity And Aging Reversal"
April 5, 2022
bottom of page
